In preclinical models of PDAC, while ablation of the tumour-restrictive α-SMA+ CAFs reduced survival, depletion of FAP+ CAFs significantly improved survival and enhanced the efficacy of immune checkpoint inhibitors (ICIs) [243]. The gene discussed is FAP; the disease is neoplasm.